MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways.
about
MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
MiR-125a-5p ameliorates monocr ...... IL-6/STAT3 signaling pathways.
@en
MiR-125a-5p ameliorates monocr ...... IL-6/STAT3 signaling pathways.
@nl
type
label
MiR-125a-5p ameliorates monocr ...... IL-6/STAT3 signaling pathways.
@en
MiR-125a-5p ameliorates monocr ...... IL-6/STAT3 signaling pathways.
@nl
prefLabel
MiR-125a-5p ameliorates monocr ...... IL-6/STAT3 signaling pathways.
@en
MiR-125a-5p ameliorates monocr ...... IL-6/STAT3 signaling pathways.
@nl
P2093
P2860
P1476
MiR-125a-5p ameliorates monocr ...... IL-6/STAT3 signaling pathways
@en
P2093
Ancai Yuan
Deming Gou
Jieyan Shen
Xueming Zhang
P2860
P2888
P356
10.1038/S12276-018-0068-3
P50
P577
2018-04-27T00:00:00Z
P6179
1103640934